Migraine Trials in Bad Homburg, Germany
Conditions / Migraine / Bad Homburg, Germany
Research into Migraine spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04396236 | A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine | TERMINATED | PHASE3 |
| NCT05748483 | Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06543914 | Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine | RECRUITING | — |
| NCT04084314 | Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study | COMPLETED | PHASE4 |
| NCT04530110 | A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents | COMPLETED | PHASE3 |
| NCT04464707 | A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age | COMPLETED | PHASE3 |
| NCT04396574 | A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine | TERMINATED | PHASE3 |
| NCT04458857 | A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age | COMPLETED | PHASE3 |
| NCT03828539 | Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine | COMPLETED | PHASE4 |
| NCT05518123 | Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications | COMPLETED | PHASE4 |